Modulation of Inducible Nitric Oxide Synthase Expression in LPS-Stimulated BV-2 Microglia by Prenylated Chalcones from Cullen corylifolium (L.) Medik. through Inhibition of I-kappa B alpha Degradation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Do Hee | - |
dc.contributor.author | Li, Hua | - |
dc.contributor.author | Han, Yeong Eun | - |
dc.contributor.author | Jeong, Ji Hye | - |
dc.contributor.author | Lee, Hwa Jin | - |
dc.contributor.author | Ryu, Jae-Ha | - |
dc.date.available | 2021-02-22T09:46:19Z | - |
dc.date.issued | 2018-01 | - |
dc.identifier.issn | 1420-3049 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/4755 | - |
dc.description.abstract | The overproduction of nitric oxide (NO) and prostaglandin E-2 (PGE(2)) by microglia may cause neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. From the activity-guided purification of Cullen corylifolium (L.) Medik. (syn. Psoralea corylifolia L.), three prenylated chalcones were identified: isobavachalcone (1), bavachromene (2), and kanzonol B (3). These prenylated chalcones showed concentration-dependent inhibitory effects on NO and PGE(2) production in lipopolysaccharide (LPS)-activated microglia. Western blotting and RT-PCR analysis demonstrated that these prenylchalcones reduced the expression of protein and mRNA of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in LPS-activated microglia. Furthermore, three prenylated chalcones blocked the inhibitory-B (I-B) degradation and down-regulated nuclear factor B (NF-B) level of nucleus in LPS-stimulated BV-2 microglia. Therefore, these prenylated chalcones from Psoralea corylifolia may be beneficial for the treatment of neuro-inflammatory diseases by modulating iNOS and COX-2 expressions in activated microglial cells. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | MDPI | - |
dc.title | Modulation of Inducible Nitric Oxide Synthase Expression in LPS-Stimulated BV-2 Microglia by Prenylated Chalcones from Cullen corylifolium (L.) Medik. through Inhibition of I-kappa B alpha Degradation | - |
dc.type | Article | - |
dc.publisher.location | 스위스 | - |
dc.identifier.doi | 10.3390/molecules23010109 | - |
dc.identifier.scopusid | 2-s2.0-85040598730 | - |
dc.identifier.wosid | 000425082500103 | - |
dc.identifier.bibliographicCitation | MOLECULES, v.23, no.1 | - |
dc.citation.title | MOLECULES | - |
dc.citation.volume | 23 | - |
dc.citation.number | 1 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | BRAIN | - |
dc.subject.keywordPlus | ISOBAVACHALCONE | - |
dc.subject.keywordPlus | PEROXYNITRITE | - |
dc.subject.keywordPlus | RECEPTOR | - |
dc.subject.keywordAuthor | Cullen corylifolium | - |
dc.subject.keywordAuthor | Psoralea corylifolia | - |
dc.subject.keywordAuthor | prenylated chalcone | - |
dc.subject.keywordAuthor | nitric oxide | - |
dc.subject.keywordAuthor | inducible nitric oxide synthase | - |
dc.subject.keywordAuthor | prostaglandin E2 | - |
dc.subject.keywordAuthor | inhibitory-kappa B alpha | - |
dc.identifier.url | https://www.mdpi.com/1420-3049/23/1/109 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.